|
L.V. Tarasova (1, 2, 3), Yu.V. Tsyganova (3), E.I. Busalaeva (3, 4), O.L. Aryamkina (1)
Analysis of the methods of treatment of non-alcoholic fatty liver disease: focus on innovations
|
№2 / 2019
|
|
E.A. Mironova (1), O.E. Berezutskaya (2), N.L. Golovkina (2)
NONALCOHOLIC FATTY LIVER DISEASE: MODERN OPPORTUNITIES OF THERAPY
|
№15 / 2016
|
|
I.V. Maev, A.N. Kazyulin, S.M. Babina
THE USE OF USING DRUGS MADE BY NEW TECHNOLOGIES IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
|
№14 / 2014
|
|
V.V. Tsukanov, O.S. Amelchugova, A.V. Vasyutin, Yu.L.Tonkikh
PATIENT WITH NAFLD: ALGORITHM FOR DIAGNOSIS AND TREATMENT
|
№18 / 2013
|
|
A.V. Ruskikh
Successful Treatment Of Acute Toxic Hepatitis In Patient With Hepatic Steatosis And Metabolic Syndrome
|
№11 / 2012
|
|
A.V. Russkikh
Application Of Thioctic Acid In Nonalcoholic Steatohepatitis
|
№12 / 2011
|
|
Severova M.M., Lopatkina T.N., Russkih A.V., Fomin V.V.
Nonalcoholic Steatohepatitis: Diagnosis And Treatment Based On Risk Factors
|
№2 / 2011
|
|
S.G. Burkov, AT Arutyunov, N.V. Yegorova, O.V. Aronova, L.I. Chugunnikova, S.A. Godunova, N.Y. Gurova, N.A. Kazakova, N.V. Shornikova
Efficacy Of Drug Hepabene In The Treatment Of Fatty Liver Disease
|
№15 / 2010
|
|
E.S. Vyuchnova, I.V. Maev, S.M. Babina
Experience Of Use Of Hepabene In The Treatment Of Non-alcoholic Steatohepatitis
|
№12 / 2010
|
|
O. Drapkina, D. Tutnov
Optimization Of Antihypertensive Therapy In Patients With Non-alcoholic Fatty Liver Disease
|
№10 / 2010
|
|
O. Drapkina, D.Tutnov
Certain Aspects Of Diagnostics And Treatment Of Cardiovascular Diseases In Combination With Non-alcoholic Steatohepatitis
|
№5 / 2010
|
Русский
